I. Figueras

A Specialized Therapeutic Approach to Chronic Urticaria Patient's Refractory to H1-Antihistamines Improves the Burden of the Disease. The Spanish AWARE Experience.

J. Bartra, M. Ferrer, I. Jáuregui, 2020, Journal of investigational allergology & clinical immunology.

Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.

M. González-Gay, G. Espinosa, S. Castañeda, 2020, Clinical and experimental rheumatology.

Sarcoidosis associated with cosmetic fillers

R. Llatjós, R. Penin, J. Marcoval, 2014, Clinical and experimental dermatology.

FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET’S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE

G. Espinosa, S. Castañeda, S. Ojeda, 2019, Poster Presentations.

Maculopapular eruptions associated to COVID‐19: A subanalysis of the COVID‐Piel study

M. Llamas-Velasco, J. Romaní, I. García-Doval, 2020, Dermatologic therapy.

Drug survival of systemic and biological treatments for moderate‐to‐severe atopic dermatitis in adults: a multicentre retrospective observational study

J. Pereyra-Rodríguez, J. Dominguez-Cruz, M. Galán, 2020, The British journal of dermatology.

[Pigmentation of the fungiform papillae of the tongue: a report of 2 cases].

J. Notario, J. Marcoval, S. Martín-Sala, 2011, Actas dermo-sifiliograficas.

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

M. López-Guerra, M. Rozman, J. Yagüe, 2023, Annals of the Rheumatic Diseases.

SAT0215 APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHÇET’S DISEASE. MULTICENTER STUDY OF 49 CASES IN CLINICAL PRACTICE

G. Espinosa, S. Castañeda, S. Ojeda, 2019, Saturday, 15 June 2019.